Across TCGA pan-cancer cohorts, DCAF13P2 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of DCAF13P2’s most consistent transcriptional readouts.
The strongest signal is observed in stomach adenocarcinoma (STAD), where DCAF13P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DCAF13P2 is over-expressed in tumor.
STAD are the cancer types where DCAF13P2 tumor–normal differential expression is most reproducible.